Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea
· Delayed Price · Currency is KRW 9,040.00
-70.00 (-0.77%)
At close: Mar 21, 2025, 3:30 PM KST
KOSDAQ:036480 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 23,804 | 25,562 | 25,500 | 23,997 | 24,801 | Upgrade
|
Other Revenue | -0 | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 23,804 | 25,562 | 25,500 | 23,997 | 24,801 | Upgrade
|
Revenue Growth (YoY) | -6.88% | 0.24% | 6.26% | -3.24% | -1.32% | Upgrade
|
Cost of Revenue | 19,872 | 20,857 | 20,855 | 18,404 | 16,903 | Upgrade
|
Gross Profit | 3,932 | 4,705 | 4,645 | 5,593 | 7,898 | Upgrade
|
Selling, General & Admin | 4,772 | 4,789 | 4,354 | 4,694 | 5,081 | Upgrade
|
Other Operating Expenses | 88.62 | 87.27 | 82.98 | 122.37 | 114.9 | Upgrade
|
Operating Expenses | 5,484 | 5,394 | 4,973 | 5,256 | 5,980 | Upgrade
|
Operating Income | -1,552 | -689.01 | -327.52 | 337.11 | 1,918 | Upgrade
|
Interest Expense | -846.16 | -892.67 | -512.58 | -277.53 | -11.19 | Upgrade
|
Interest & Investment Income | 296.55 | 374.42 | 213.88 | 119.03 | 152.32 | Upgrade
|
Earnings From Equity Investments | -27.7 | 36.39 | -14.6 | -4.97 | - | Upgrade
|
Currency Exchange Gain (Loss) | 548.48 | 58.67 | 478.31 | 566.84 | -443.49 | Upgrade
|
Other Non Operating Income (Expenses) | -6.56 | 30.83 | 205.01 | 95.4 | -97.95 | Upgrade
|
EBT Excluding Unusual Items | -1,587 | -1,081 | 42.49 | 835.87 | 1,517 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.19 | -0.29 | -0.91 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 16.26 | -0.07 | 2,219 | 7 | 11.72 | Upgrade
|
Pretax Income | -1,571 | -1,082 | 2,261 | 842.87 | 1,529 | Upgrade
|
Income Tax Expense | 198.32 | -402.05 | 557.38 | -23.05 | 10.55 | Upgrade
|
Net Income | -1,769 | -679.68 | 1,703 | 865.92 | 1,519 | Upgrade
|
Net Income to Common | -1,769 | -679.68 | 1,703 | 865.92 | 1,519 | Upgrade
|
Net Income Growth | - | - | 96.69% | -42.98% | -38.54% | Upgrade
|
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | Upgrade
|
Shares Change (YoY) | -0.00% | -0.12% | -0.34% | 0.47% | -0.13% | Upgrade
|
EPS (Basic) | -466.00 | -179.00 | 448.00 | 227.00 | 400.00 | Upgrade
|
EPS (Diluted) | -466.00 | -179.00 | 448.00 | 227.00 | 400.00 | Upgrade
|
EPS Growth | - | - | 97.36% | -43.25% | -38.46% | Upgrade
|
Free Cash Flow | 1,308 | -2,490 | -1,160 | -764.71 | -10,770 | Upgrade
|
Free Cash Flow Per Share | 344.42 | -655.75 | -305.03 | -200.47 | -2836.73 | Upgrade
|
Gross Margin | 16.52% | 18.40% | 18.22% | 23.31% | 31.85% | Upgrade
|
Operating Margin | -6.52% | -2.70% | -1.28% | 1.41% | 7.73% | Upgrade
|
Profit Margin | -7.43% | -2.66% | 6.68% | 3.61% | 6.12% | Upgrade
|
Free Cash Flow Margin | 5.49% | -9.74% | -4.55% | -3.19% | -43.43% | Upgrade
|
EBITDA | 163.17 | 2,173 | 2,378 | 2,875 | 3,865 | Upgrade
|
EBITDA Margin | 0.69% | 8.50% | 9.33% | 11.98% | 15.59% | Upgrade
|
D&A For EBITDA | 1,715 | 2,862 | 2,706 | 2,538 | 1,948 | Upgrade
|
EBIT | -1,552 | -689.01 | -327.52 | 337.11 | 1,918 | Upgrade
|
EBIT Margin | -6.52% | -2.70% | -1.28% | 1.41% | 7.73% | Upgrade
|
Effective Tax Rate | - | - | 24.66% | - | 0.69% | Upgrade
|
Advertising Expenses | 149.24 | 176.8 | 51.04 | 122.44 | 93.24 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.